JPH04131082A - Production of non-aqueous highly active enzyme - Google Patents
Production of non-aqueous highly active enzymeInfo
- Publication number
- JPH04131082A JPH04131082A JP2251853A JP25185390A JPH04131082A JP H04131082 A JPH04131082 A JP H04131082A JP 2251853 A JP2251853 A JP 2251853A JP 25185390 A JP25185390 A JP 25185390A JP H04131082 A JPH04131082 A JP H04131082A
- Authority
- JP
- Japan
- Prior art keywords
- enzyme
- surfactant
- lipid
- highly active
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 65
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 65
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- 150000002632 lipids Chemical class 0.000 claims abstract description 37
- 239000004094 surface-active agent Substances 0.000 claims abstract description 30
- 239000000243 solution Substances 0.000 claims abstract description 15
- 239000007853 buffer solution Substances 0.000 claims abstract description 14
- 238000001816 cooling Methods 0.000 claims abstract description 7
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 abstract description 11
- 239000002699 waste material Substances 0.000 abstract description 7
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 abstract description 4
- 239000005639 Lauric acid Substances 0.000 abstract description 2
- QUZHZFAQJATMCA-UHFFFAOYSA-N Monogalactosyldiglyceride Natural products CCC=CCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCC=CCC)COC1OC(CO)C(O)C(O)C1O QUZHZFAQJATMCA-UHFFFAOYSA-N 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 48
- 241000047703 Nonion Species 0.000 description 15
- -1 phosphogesterase Proteins 0.000 description 12
- 239000003960 organic solvent Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000000872 buffer Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 102000004195 Isomerases Human genes 0.000 description 3
- 108090000769 Isomerases Proteins 0.000 description 3
- 108090001060 Lipase Proteins 0.000 description 3
- 239000004367 Lipase Substances 0.000 description 3
- 102000004882 Lipase Human genes 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- PZQBWGFCGIRLBB-NJYHNNHUSA-N [(2r)-2-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1O PZQBWGFCGIRLBB-NJYHNNHUSA-N 0.000 description 3
- 239000008351 acetate buffer Substances 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 235000019421 lipase Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108090000371 Esterases Proteins 0.000 description 2
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 2
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108090000279 Peptidyltransferases Proteins 0.000 description 2
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 2
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 2
- 108090000992 Transferases Proteins 0.000 description 2
- 102000004357 Transferases Human genes 0.000 description 2
- UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical compound CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- YLYBTZIQSIBWLI-UHFFFAOYSA-N octyl acetate Chemical compound CCCCCCCCOC(C)=O YLYBTZIQSIBWLI-UHFFFAOYSA-N 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 235000019833 protease Nutrition 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000004402 sodium ethyl p-hydroxybenzoate Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000003381 solubilizing effect Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- AJDONJVWDSZZQF-UHFFFAOYSA-N 1-(2,4,4-trimethylpentan-2-yl)-4-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]benzene Chemical compound C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OC1=CC=C(C(C)(C)CC(C)(C)C)C=C1 AJDONJVWDSZZQF-UHFFFAOYSA-N 0.000 description 1
- FFYRIXSGFSWFAQ-UHFFFAOYSA-N 1-dodecylpyridin-1-ium Chemical class CCCCCCCCCCCC[N+]1=CC=CC=C1 FFYRIXSGFSWFAQ-UHFFFAOYSA-N 0.000 description 1
- MRTWZIXSCCETHN-UHFFFAOYSA-N 2-sulfododecanoic acid Chemical compound CCCCCCCCCCC(C(O)=O)S(O)(=O)=O MRTWZIXSCCETHN-UHFFFAOYSA-N 0.000 description 1
- CJAJEZSCULAKCB-UHFFFAOYSA-N 2-sulfohexadecanoic acid Chemical compound CCCCCCCCCCCCCCC(C(O)=O)S(O)(=O)=O CJAJEZSCULAKCB-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ZLAJEWCTXKXIPN-UHFFFAOYSA-N 3-dodecoxy-3-oxopropanoic acid Chemical compound CCCCCCCCCCCCOC(=O)CC(O)=O ZLAJEWCTXKXIPN-UHFFFAOYSA-N 0.000 description 1
- TWVLIAALYDUWFK-UHFFFAOYSA-N 3-octoxy-3-oxopropanoic acid Chemical compound CCCCCCCCOC(=O)CC(O)=O TWVLIAALYDUWFK-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 108010009924 Aconitate hydratase Proteins 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 108700023418 Amidases Proteins 0.000 description 1
- 108090000531 Amidohydrolases Proteins 0.000 description 1
- 102000004092 Amidohydrolases Human genes 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- 102000004452 Arginase Human genes 0.000 description 1
- 108700024123 Arginases Proteins 0.000 description 1
- 108700016171 Aspartate ammonia-lyases Proteins 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- TYYDXNISHGVDGA-UHFFFAOYSA-N Corotoxigenin Natural products CC12CCC3C(CCC4CC(O)CCC34C=O)C1CCC2C5=CC(=O)OC5 TYYDXNISHGVDGA-UHFFFAOYSA-N 0.000 description 1
- 102100039868 Cytoplasmic aconitate hydratase Human genes 0.000 description 1
- 101000874334 Dalbergia nigrescens Isoflavonoid 7-O-beta-apiosyl-glucoside beta-glycosidase Proteins 0.000 description 1
- 102000004860 Dipeptidases Human genes 0.000 description 1
- 108090001081 Dipeptidases Proteins 0.000 description 1
- 101000757733 Enterococcus faecalis (strain ATCC 700802 / V583) Autolysin Proteins 0.000 description 1
- 102000013382 Gelatinases Human genes 0.000 description 1
- 108010026132 Gelatinases Proteins 0.000 description 1
- 108010073324 Glutaminase Proteins 0.000 description 1
- 102000009127 Glutaminase Human genes 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 101000757734 Mycolicibacterium phlei 38 kDa autolysin Proteins 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 102000004020 Oxygenases Human genes 0.000 description 1
- 108090000417 Oxygenases Proteins 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 1
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102000009609 Pyrophosphatases Human genes 0.000 description 1
- 108010009413 Pyrophosphatases Proteins 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 108090001109 Thermolysin Proteins 0.000 description 1
- 108060008539 Transglutaminase Proteins 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- FOLJTMYCYXSPFQ-CJKAUBRRSA-N [(2r,3s,4s,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-(octadecanoyloxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl octadecanoate Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)O[C@@H]1O[C@@]1(COC(=O)CCCCCCCCCCCCCCCCC)[C@@H](O)[C@H](O)[C@@H](CO)O1 FOLJTMYCYXSPFQ-CJKAUBRRSA-N 0.000 description 1
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 150000001346 alkyl aryl ethers Chemical class 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 102000005922 amidase Human genes 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 210000001557 animal structure Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 108010019077 beta-Amylase Proteins 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000005131 dialkylammonium group Chemical group 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- TWFQJFPTTMIETC-UHFFFAOYSA-N dodecan-1-amine;hydron;chloride Chemical compound [Cl-].CCCCCCCCCCCC[NH3+] TWFQJFPTTMIETC-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 150000002339 glycosphingolipids Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- QMGPXBPMUADRMC-UHFFFAOYSA-M heptyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCC[N+](C)(C)C QMGPXBPMUADRMC-UHFFFAOYSA-M 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- UZZYXUGECOQHPU-UHFFFAOYSA-M n-octyl sulfate Chemical compound CCCCCCCCOS([O-])(=O)=O UZZYXUGECOQHPU-UHFFFAOYSA-M 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940067739 octyl sulfate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- UZZYXUGECOQHPU-UHFFFAOYSA-N sulfuric acid monooctyl ester Natural products CCCCCCCCOS(O)(=O)=O UZZYXUGECOQHPU-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 102000003601 transglutaminase Human genes 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、医薬品工業、食品工業、農水産分野及び有機
中間原料製造分野等において、エステル類やペプチド類
等の生理活性物質、及び光学活性な有機中間原料等の製
造に使用する非水系高活性酵素の製造方法に関するもの
である。Detailed Description of the Invention [Industrial Field of Application] The present invention is useful in the pharmaceutical industry, food industry, agriculture and fishery fields, organic intermediate raw material production fields, etc. The present invention relates to a method for producing a non-aqueous highly active enzyme used in the production of organic intermediate raw materials.
酵素の優れた特性を有機合成に有効に利用するためには
、基質及び生成物の溶解層の点から有機溶媒の使用が必
須である。In order to effectively utilize the excellent properties of enzymes in organic synthesis, it is essential to use organic solvents from the standpoint of dissolving substrates and products.
従来、有m溶媒中における酵素反応としては、酵素を有
機溶媒に?A濁させ反応させる不均一系の反応(A、M
、K11banov et al、、 CHEMTEC
)1.16.354(1986) )と、酵素を有IR
’l@媒に完全に熔解させ反応させる均−系の反応があ
る。Conventionally, enzyme reactions in organic solvents involve using enzymes in organic solvents. Heterogeneous reaction (A, M
, K11banov et al., CHEMTEC
) 1.16.354 (1986) ) and enzymes with IR
There is a homogeneous reaction in which the substance is completely dissolved in a medium and reacts.
不均一系の反応においては、酵素が有機溶媒に懸濁して
いるため、基質の酵素内部への拡散が低く、反応性が低
い。そのため均−形系の反応が望ましいが、そのために
は酵素を可溶化する必要がある。In a heterogeneous reaction, since the enzyme is suspended in an organic solvent, diffusion of the substrate into the enzyme is low, resulting in low reactivity. Therefore, a homogeneous reaction is desirable, but for this purpose it is necessary to solubilize the enzyme.
酵素の可溶化方法としては、酵素をポリエチレングリコ
ールで修飾し、有機ン容媒に可溶化する方法(Y、In
ada et al、、Biochem、Biophy
s、Res、Commun、、」η、 845 (19
134))があるが、調製方法が煩雑である。また、酵
素と脂質の複合体を形成さセ、有I!溶媒に可溶化する
方法(特開昭64−80282)があるが、複合体中に
含まれる酵素量が低く、かつ複合体の収量も低い等の問
題点がある。As a method for solubilizing the enzyme, the enzyme is modified with polyethylene glycol and solubilized in an organic medium (Y, In
ada et al, Biochem, Biophy
s,Res,Commun,,”η, 845 (19
134)), but the preparation method is complicated. In addition, complexes between enzymes and lipids are formed. Although there is a method of solubilizing the enzyme in a solvent (Japanese Patent Laid-Open No. 64-80282), there are problems such as the amount of enzyme contained in the complex is low and the yield of the complex is also low.
本発明者は先に酵素と界面活性剤と脂質の複合体である
有機溶媒に可溶な非水系高活性酵素を見出し特許出願を
した(特願平2−081040号)。該複合体よりなる
酵素は例えば酵素をpu 5.0〜9.0の緩衝液に溶
解させておき、これに緩衝液に溶解させた界面活性剤を
滴下混合し、脂質を分散させこれを低温下に放置するこ
とにより複合体を析出させることにより製造することが
できる。しかし、この方法による場合は使用する酵素の
うち複合体となる割合は必ずしも多くなく、かなりの部
分が廃液中に残存してしまうという欠点を有していた。The present inventor previously discovered a non-aqueous highly active enzyme that is a complex of an enzyme, a surfactant, and a lipid and is soluble in organic solvents and filed a patent application (Japanese Patent Application No. 2-081040). For example, the enzyme made of the complex is prepared by dissolving the enzyme in a buffer solution with a pu of 5.0 to 9.0, adding a surfactant dissolved in the buffer solution dropwise, dispersing the lipids, and then heating the solution at a low temperature. It can be produced by allowing the composite to precipitate by standing under. However, this method has the disadvantage that the proportion of the enzyme used that forms a complex is not necessarily large, and a considerable portion remains in the waste liquid.
[発明が解決しようとする課題]
本発明が解決しようとする課題は、前記酵素、界面活性
剤および脂質の複合体である非水系高活性酵素の製造プ
ロセスから排出される廃液中の酵素等を有効に利用し、
これより非水系高活性酵素を製造する方法を提供するこ
とである。[Problem to be Solved by the Invention] The problem to be solved by the present invention is to remove enzymes, etc. from the waste liquid discharged from the manufacturing process of the non-aqueous highly active enzyme, which is a complex of the enzyme, surfactant, and lipid. Make effective use of
The object of the present invention is to provide a method for producing a non-aqueous highly active enzyme.
[課題を解決するための手段〕
上記本発明の目的は、酵素、界面活性剤および脂質が溶
解してなる緩衝液に、更に界面活性剤を溶解し、脂質を
分散し、冷却することを特徴とする、酵素と界面活性剤
と脂質の複合体である非水系高活性酵素を製造する方法
により達成される。[Means for Solving the Problems] The object of the present invention is to further dissolve a surfactant in a buffer solution containing an enzyme, a surfactant, and a lipid, disperse the lipid, and cool the solution. This is achieved by a method for producing a non-aqueous highly active enzyme, which is a complex of an enzyme, a surfactant, and a lipid.
本発明における酵素、界面活性剤および脂質が溶解して
なる緩衝液とは、pH5,0〜9.0の緩衝液に酵素、
界面活性剤および脂質を溶解または分散したものでもよ
いが、本発明の目的からすれば前記特願平2−0810
40号の非水系高活性酵素を製造した廃液を使用するの
が好適である。すなわち、酵素をpH5,0〜9.0の
緩衝液に熔解させておき、これに緩衝液に溶解させた界
面活性剤を滴下混合し、これを低温下に放置冷却するこ
とにより複合体を析出させ、この析出した複合体を除い
たあとの液を使用する。さらには本発明に従って製造し
た非水系高活性酵素の廃液でもよい。In the present invention, the buffer solution in which enzymes, surfactants, and lipids are dissolved refers to the enzyme, surfactant, and lipid dissolved in a buffer solution with a pH of 5.0 to 9.0.
A solution or dispersion of a surfactant and a lipid may also be used, but for the purpose of the present invention,
It is preferable to use the waste liquid from which No. 40 non-aqueous highly active enzyme was produced. That is, the enzyme is dissolved in a buffer solution with a pH of 5.0 to 9.0, a surfactant dissolved in the buffer solution is added dropwise to the solution, and the complex is precipitated by leaving it to cool at a low temperature. and use the solution after removing this precipitated complex. Furthermore, a waste liquid of a non-aqueous highly active enzyme produced according to the present invention may also be used.
緩衝液中の酵素の濃度は0.7g/111以上である。The concentration of enzyme in the buffer is 0.7 g/111 or more.
0.7u/d未満では複合体が析出しない。At less than 0.7 u/d, the composite does not precipitate.
本発明に使用できる酵素としては、加水分解酵素、転移
酵素、酸化還元酵素、付加酵素及び異性化酵素等を挙げ
ることができる。Examples of enzymes that can be used in the present invention include hydrolases, transferases, oxidoreductases, addition enzymes, and isomerases.
加水分解酵素としてはエステラーゼ、ペプチダーゼ、グ
リコシダーゼ、ホスファターゼ、アミダーゼ等があげら
れる。Examples of hydrolytic enzymes include esterase, peptidase, glycosidase, phosphatase, and amidase.
エステルを加水分解するエステラーゼでは、リパーゼも
しくはリパーゼを含有する生体組織を用いることができ
る。それらは微生物により生産されたものでもよいし、
動物の臓器や植物の種子等から得られたものでもよい。As an esterase that hydrolyzes esters, lipase or a living tissue containing lipase can be used. They may be produced by microorganisms,
It may also be obtained from animal organs, plant seeds, etc.
ペプチドを加水分解するペプチダーゼでは、動物由来の
ペプシン、キモトリプシン、カルボキシペプチダーゼ、
サーモライシン;植物由来のパパイン、ブロメリン、ア
ミノペプチダーゼ;バクテリア由来のゲラチナーゼ、ジ
ペプチダーゼ等が挙げられる。糖のゲルコント結合に作
用するグリコシダーゼでは、α−及びβ−グリコシダー
ゼ、α−及びβ−ガラクシダーゼ等のオリゴサッカラー
ゼ、α−及びβ−アミラーゼ、セルラーゼ等のポリサン
カラーゼ等が挙げられる。リン酸結合の加水分解に関与
するホスファターゼでは、ホスホモノエステラーゼ、ホ
スホジェステラーゼ、ピロホスファターゼ等が挙げられ
る。アミド基を加水分解するアミダーゼでは、アルギナ
ーゼ、ウレアーゼ、グルタミナーゼ等が挙げられる。Peptidases that hydrolyze peptides include animal-derived pepsin, chymotrypsin, carboxypeptidase,
Examples include thermolysin; plant-derived papain, bromelin, and aminopeptidase; and bacterial-derived gelatinase and dipeptidase. Examples of glycosidases that act on Gelconte bonds of sugars include oligosaccharases such as α- and β-glycosidases, α- and β-galaxidases, polysancarases such as α- and β-amylases, and cellulases. Phosphatases involved in hydrolysis of phosphate bonds include phosphomonoesterase, phosphogesterase, pyrophosphatase, and the like. Amidases that hydrolyze amide groups include arginase, urease, glutaminase, and the like.
加水分解酵素以外の酵素としては、トランスペプチダー
ゼ、トランスグルコシダーゼ、トランスペプチダーゼ、
トランスアミダーゼ、トランスグルタミナーゼ等の転移
酵素;アルコールデヒドロゲナーゼ、オキシゲナーゼ等
の酸化還元酵素;アコニターゼ、エノラーゼ、アスパル
ターゼ等の付加酵素;イソメラーゼ等の異性化酵素等が
挙げられる。Enzymes other than hydrolytic enzymes include transpeptidase, transglucosidase, transpeptidase,
Examples include transferases such as transamidase and transglutaminase; oxidoreductases such as alcohol dehydrogenase and oxygenase; addition enzymes such as aconitase, enolase and aspartase; and isomerases such as isomerase.
本発明に用いられる界面活性剤は、非イオン系のものと
して、トリトンX−100等のポリオキシエチレンp−
t−オクチルフェニルエーテル;ディスホームCA−1
15;ノニオンE−215、ノニオンP−210等のポ
リエチレングリコールモノアルキルエーテル;ノニオン
NS−210,ノニオンH8−210等のポリエチレン
グリコール−p−アルキルフェニルエーテル;ノニオン
し−4、ノニオンS−6等のポリエチレングリコール脂
肪酸;スパン80、スパン85等のソルビタン脂肪酸;
ツウィーン20、ノニオンS−221等のソルビタンエ
ステルエーテル脂肪酸等が挙げられる。ここで、ディス
ホームCA−115、ノニオンE−215、ノニオンP
−210、ノニオンNS−210、ノニオンH320、
ノニオンL−4、ノニオンS−6、スパン80、スパン
85、ツウィーン20、ノニオンLT−221は日本油
脂■製の商品名である。アニオン系のものとして、ラウ
リル酸、ミリスチン酸、パルミチン酸、ステアリン酸、
オレイン酸等の脂肪酸とその塩;オクチルマロン酸塩、
ドデシルマロン酸塩等のアルキルマロン酸塩;オクチル
硫酸塩、デンル硫酸塩、ドデシル硫酸塩等のアルカンス
ルホン酸塩;α−スルホラウリン酸、α−スルホパルミ
チン酸等のα−スルホ脂肪酸である。カチオン系のもの
として、N−ドデシルピリジニウム塩等のN−アルキル
ピリジニウム塩、ドデシルアンモニウムクロライド、七
チルトリメチルアンモニウムクロライド等のアルキルア
ンモニウム塩等が挙げられる。The surfactant used in the present invention is a nonionic surfactant such as polyoxyethylene p-
t-Octyl phenyl ether; Disform CA-1
15; Polyethylene glycol monoalkyl ethers such as Nonion E-215 and Nonion P-210; Polyethylene glycol-p-alkylphenyl ethers such as Nonion NS-210 and Nonion H8-210; Nonion Shi-4, Nonion S-6, etc. Polyethylene glycol fatty acids; sorbitan fatty acids such as Span 80 and Span 85;
Examples include sorbitan ester ether fatty acids such as Tween 20 and Nonion S-221. Here, Disform CA-115, Nonion E-215, Nonion P
-210, Nonion NS-210, Nonion H320,
Nonion L-4, Nonion S-6, Span 80, Span 85, Tween 20, and Nonion LT-221 are trade names manufactured by NOF ■. Anionic acids include lauric acid, myristic acid, palmitic acid, stearic acid,
Fatty acids and their salts such as oleic acid; octyl malonate,
These include alkyl malonates such as dodecyl malonate; alkanesulfonates such as octyl sulfate, delen sulfate, and dodecyl sulfate; and α-sulfo fatty acids such as α-sulfolauric acid and α-sulfopalmitic acid. Examples of cationic salts include N-alkylpyridinium salts such as N-dodecylpyridinium salts, alkyl ammonium salts such as dodecyl ammonium chloride, and heptyltrimethylammonium chloride.
本発明に用いることのできる脂質は、例えば、天然に存
在するものとしては、中性脂質、アニオン性脂質、両性
脂質等がある。Lipids that can be used in the present invention include, for example, naturally occurring lipids such as neutral lipids, anionic lipids, and amphoteric lipids.
中性脂質では、モノガラクトシルジグリセリド、ガラク
トシルグルコシルジグリセリド等のグリセロ糖脂質;モ
ノグリコジルセラミド、セラミドへキソシド、ガングリ
オシド等のスフィンゴ糖脂質;ステロール配糖体、カル
デノリド配糖体、サポニン等のステロイド配糖体;ジア
シルトレハロース、トリアジルグルコース、ソルビタン
ジステアリン酸エステル、ショ糖ジステアリン酸エステ
ル等の脂肪酸糖等を挙げることができる。アニオン性脂
質では、ホスファチジルイノシトール、ホスファチジル
グリセロール、ホスファチジン酸等のリン脂質、また、
両性脂質では、ホスファチジルコリン、ホスファチジル
エタノールアミン、ホスファチジルセリン等のリン脂質
等を挙げることができる。Neutral lipids include glyceroglycolipids such as monogalactosyl diglyceride and galactosyl glucosyl diglyceride; glycosphingolipids such as monoglycodylceramide, ceramide hexoside, and ganglioside; steroid glycosides such as sterol glycosides, cardenolide glycosides, and saponins. Examples include fatty acid sugars such as diacyltrehalose, triadylglucose, sorbitan distearate, and sucrose distearate. Anionic lipids include phospholipids such as phosphatidylinositol, phosphatidylglycerol, and phosphatidic acid;
Examples of amphoteric lipids include phospholipids such as phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine.
合成脂質としては、炭素数6〜30の2本の炭化水素鎖
を疎水部分とし、糖等のポリヒドロキシ基、リン酸基、
スルホンt11基、アンモニウム塩等の官能基を親水部
分として有する合成2分子膜形成化合物を用いることが
できる。具体的には、ジアルキルホスフェート、ジアル
キル型ポリエチレングリコール、ジアルキルスルホコハ
ク酸、ジアルキル型糖脂質、ジアルキルアンモニウム塩
等を挙げることができる。Synthetic lipids include two hydrocarbon chains with 6 to 30 carbon atoms as hydrophobic parts, polyhydroxy groups such as sugars, phosphate groups,
A synthetic bilayer membrane-forming compound having a functional group such as a sulfone t11 group or an ammonium salt as a hydrophilic moiety can be used. Specifically, dialkyl phosphates, dialkyl polyethylene glycols, dialkyl sulfosuccinic acids, dialkyl glycolipids, dialkyl ammonium salts and the like can be mentioned.
全界面活性剤の全酵素に対する割合は0.001〜10
00 (界面活性剤重量/酵素重量)であり、緩衝液に
予め溶解しているものと後から添加したものの区別はな
い。緩衝液に海面活性剤を熔解するには常法に従えばよ
い。The ratio of total surfactant to total enzyme is 0.001-10
00 (surfactant weight/enzyme weight), and there is no distinction between those dissolved in the buffer beforehand and those added later. A conventional method may be used to dissolve the surfactant in the buffer solution.
脂tは少1のメタノール、エタノール、プロパツール、
アセトン、メチルエチルケトン、その他の親水性有機溶
媒もしくは緩衝液に熔解し、またはそのまま用いる。For fat, use 1 small amount of methanol, ethanol, propatool,
Dissolve in acetone, methyl ethyl ketone, other hydrophilic organic solvents or buffers, or use as is.
全脂質の全酵素に対する割合は0.2〜100(脂質重
量/酵素重量)であり、緩衝液に予め溶解しているもの
と後から添加したものの区別はない。The ratio of total lipids to total enzymes is 0.2 to 100 (lipid weight/enzyme weight), and there is no distinction between those dissolved in the buffer solution in advance and those added later.
脂質の分散方法は、攪拌羽根やマグネチックスタラー、
ホモミキサー等の撹拌装置を用いてもよいし、超音波を
かけて分散させてもよい。Lipid dispersion methods include stirring blades, magnetic stirrers,
A stirring device such as a homomixer may be used, or ultrasonic waves may be applied for dispersion.
脂質を十分に分散後、緩衝液を0〜30℃、好ましくは
、0〜10°Cに放置することにより、酵素と界面活性
剤と脂質の複合体を析出し、沈澱させる。この時、上澄
液には酵素、界面活性剤及び脂質が溶解している。この
上澄液は再度本発明の緩衝液として使用可能である。After the lipids are sufficiently dispersed, the buffer solution is allowed to stand at 0 to 30°C, preferably 0 to 10°C, to precipitate and precipitate the enzyme-surfactant-lipid complex. At this time, enzymes, surfactants, and lipids are dissolved in the supernatant. This supernatant can be used again as a buffer in the present invention.
この沈澱物をを遠心分離または濾過等により分離した後
、緩衝液、次いで蒸留水で洗浄し、そのまま凍結乾燥や
流動層乾燥し、または、少量の蒸留水に分散させた後に
、スプレー乾燥することにより、粉末状の非水系高活性
酵素を得る。After separating this precipitate by centrifugation or filtration, it is washed with a buffer solution and then with distilled water, and then it is freeze-dried or fluidized bed-dried as it is, or it is dispersed in a small amount of distilled water and then spray-dried. A powdered non-aqueous highly active enzyme is obtained.
以下、本発明を実施例により、詳細に説明する。 Hereinafter, the present invention will be explained in detail with reference to Examples.
実、雄側1
キャンディダ・シリンドラセ(Candid Cyli
n−dracea )由来のリパーゼ501gを酢酸緩
衝液(0,01M、 p H6,0) 25mに溶解後
、遠心沈腎させて、不溶物を除いた(a液)。非イオン
界面活性剤(ノニオンLT−221:商品名、日本油脂
■製)50■を酢酸緩衝液(0,01M、 p H6,
0) 25mに熔解した(b液)。a液にb液を4°C
に冷却しながら滴下し、1時間攪拌したa液に非イオン
脂質(ソルビタンジステアリン酸エステル)50■をエ
タノール0.5社に溶解したd液を4℃に冷却しながら
滴下し、攪拌して、滴下後、5°Cで24時間放置した
。放置後、白色沈澱が生成した溶液を遠心分離させ、上
澄液を取り除き、残った固体を酢M緩衝液で2回、蒸留
水で1回洗浄した。その後、この固体を凍結乾燥させ、
24.8■の粉末を得た。Fruit, male side 1 Candid Cyli
After dissolving 501 g of lipase derived from S. n-dracea in 25 m of acetate buffer (0.01 M, pH 6.0), it was centrifuged to remove insoluble matter (solution a). 50μ of a nonionic surfactant (Nonion LT-221: trade name, manufactured by NOF Corporation) was added to an acetate buffer (0.01M, pH 6,
0) Melted to 25m (liquid b). Add solution B to solution A at 4°C.
Add dropwise while cooling to 4°C and stir for 1 hour.To solution A, add dropwise solution D, which is a solution of 50 μm of nonionic lipid (sorbitan distearate) dissolved in 0.5% ethanol, while cooling to 4°C, and stir. After dropping, it was left at 5°C for 24 hours. After standing, the solution in which a white precipitate was formed was centrifuged, the supernatant was removed, and the remaining solid was washed twice with vinegar M buffer and once with distilled water. This solid is then freeze-dried,
24.8 μg of powder was obtained.
更に白色沈澱を取り除いた後の上澄液にb液を4°Cに
冷却しながら滴下し、1時間攪拌した液に非イオン脂質
(ソルビタンジステアリン酸エステル)25■をエタノ
ール0.5dに溶解したa液を4°Cに冷却しながら滴
下し、攪拌して、滴下後、5°Cで24時間放置した。Furthermore, after removing the white precipitate, liquid B was added dropwise to the supernatant liquid while cooling it to 4°C, and after stirring for 1 hour, 25 μm of nonionic lipid (sorbitan distearate) was dissolved in 0.5 d of ethanol. Solution a was added dropwise while cooling to 4°C, stirred, and left at 5°C for 24 hours after the dropwise addition.
以下前述の方法に従い17.91gの白色粉末を得た。Following the method described above, 17.91 g of white powder was obtained.
この回収操作を計4回行った。This collection operation was performed a total of four times.
第1表にその結果を示す。Table 1 shows the results.
得られた酵素と界面活性剤と脂質の複合体は、UVスペ
クトルと元素分析によって酵素を同定した。この複合体
は、水に不溶でベンゼン、クロロホルムの有機溶媒に可
溶であった。The enzyme of the obtained complex of enzyme, surfactant, and lipid was identified by UV spectrum and elemental analysis. This complex was insoluble in water and soluble in organic solvents such as benzene and chloroform.
次に、この酵素と界面活性剤と脂質の複合体1.61g
をトリブチリン1〆に溶解させ、さらに、オクタツール
1.52Mを溶解し、水分含量が1容量%になるように
水を添加した。その後、22°Cにて30分間攪拌した
。 生成した酢酸オクチルをガスクロマトグラフ分析に
より測定した。Next, 1.61 g of this enzyme, surfactant, and lipid complex
was dissolved in 1.52 M of tributyrin, and 1.52 M of octatool was further dissolved, and water was added so that the water content was 1% by volume. Thereafter, the mixture was stirred at 22°C for 30 minutes. The produced octyl acetate was measured by gas chromatographic analysis.
この値から次の式で合成率を求めた。From this value, the synthesis rate was calculated using the following formula.
第1表に、複合体の収量、複合体中の酵素含有量及び合
成率を示す。Table 1 shows the yield of the complex, the enzyme content in the complex and the synthesis rate.
実施例2
実施例】で用いた界面活性剤に代えて、第2表に示す界
面活性剤50■を酢酸緩衝液(0,01M、 pH6,
0) 25mに溶解し、b液とした。Example 2 Instead of the surfactant used in Example, 50μ of the surfactant shown in Table 2 was added to an acetate buffer (0.01M, pH 6,
0) It was dissolved in 25m and used as liquid b.
以下、実施例1と同様の操作により白色の粉末を得た。Thereafter, a white powder was obtained by the same operation as in Example 1.
その結果を第2表に示す。The results are shown in Table 2.
第1表
第2表
〔発明の効果〕
本発明の方法によれば非水系高活性酵素を製造した廃液
からさらに非水系高活性酵素を高収率で製造することが
できる。Table 1 Table 2 [Effects of the Invention] According to the method of the present invention, a non-aqueous highly active enzyme can be further produced in high yield from the waste liquid from which the non-aqueous highly active enzyme was produced.
Claims (2)
質が溶解してなる緩衝液に更に界面活性剤を溶解し、脂
質を分散し、冷却することを特徴とする、酵素、界面活
性剤および脂質の複合体である非水系高活性酵素を製造
する方法。(1) Enzymes and surfactants characterized by dissolving a surfactant in a buffer solution containing 0.7 mg/ml or more of an enzyme, a surfactant, and a lipid, dispersing the lipid, and cooling the solution. A method for producing a nonaqueous highly active enzyme that is a complex of an agent and a lipid.
0.001〜1000(界面活性剤重量/酵素重量)で
あり、酵素の重量に対する全脂質の重量の比が、0.2
〜100(脂質重量/酵素重量)である請求項1記載の
非水系高活性酵素を製造する方法。(2) The ratio of the weight of total surfactant to the weight of enzyme is
0.001 to 1000 (surfactant weight/enzyme weight), and the ratio of total lipid weight to enzyme weight is 0.2
2. The method for producing a non-aqueous highly active enzyme according to claim 1, wherein the ratio is 100 to 100 (lipid weight/enzyme weight).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2251853A JPH04131082A (en) | 1990-09-25 | 1990-09-25 | Production of non-aqueous highly active enzyme |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2251853A JPH04131082A (en) | 1990-09-25 | 1990-09-25 | Production of non-aqueous highly active enzyme |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04131082A true JPH04131082A (en) | 1992-05-01 |
Family
ID=17228897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2251853A Pending JPH04131082A (en) | 1990-09-25 | 1990-09-25 | Production of non-aqueous highly active enzyme |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04131082A (en) |
-
1990
- 1990-09-25 JP JP2251853A patent/JPH04131082A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4593697B2 (en) | Stabilized additive in water-soluble pharmaceutical preparation of lipase and protease-containing digestive enzyme mixture, preparation containing the additive and kit for producing digestive enzyme mixture | |
SK9292003A3 (en) | Novel mixtures of microbial enzymes | |
CN107034205B (en) | Method for preparing high-esterification-activity lipase by using surfactant | |
De La Casa et al. | Modification of the activities of two different lipases from Candida rugosa with dextrans | |
JPH1081655A (en) | Production of sphingolipid and sphingolipid derivative | |
Assmann et al. | Positional specificity of triglyceride lipases in post-heparin plasma | |
Matsumoto | Studies on phospholipids II. Phospholipase activity of Clostridium perfringens toxin | |
US5082769A (en) | Aqueous solution of triglyceride substrate for determination of lipase | |
JPH03280880A (en) | Non-aqueous highly active enzyme | |
JPH04131082A (en) | Production of non-aqueous highly active enzyme | |
Nagao et al. | Lipase-catalyzed synthesis of fatty acid esters useful in the food industry | |
Boucrot et al. | Resistance to the effect of phospholipase A2 of the biliary phospholipids during incubation of bile | |
Niino et al. | Characterization of human salivary esterase in enzymatic hydrolysis of phthalate esters | |
JPH0279990A (en) | Production of phosphatidylserine | |
Sugatani et al. | In vitro actions of some antibiotics on phospholipases | |
Radominska-Pyrek et al. | Synthesis and content of ether-linked glycerophospholipids in the harderian gland of rabbits | |
US6924130B1 (en) | Enzymatic transesterification or hydrolysis of phospholipids in aqueous media | |
Hilton et al. | Action of a microbial lipase/acyltransferase on phospholipid monolayers | |
JP3218794B2 (en) | New surfactant-coated enzyme and its manufacturing method. | |
JPS6342691A (en) | Modification of phospholipid | |
Patelski et al. | Cholesterol Ester: Lysolecithin Transacylation in the Aorta1 | |
JP2886627B2 (en) | Method for producing phospholipid | |
Triantafyllou et al. | Lipolytic and esterolytic activities in posterior lingual glands of rat: a histochemical study | |
JP3301489B2 (en) | How to use chemically modified esterase | |
Nieder | PARTIAL PURIFICATION AND CHARACTERIZATION OF A PHOSPHOLIPASE A1 FROM THE HEMOLYMPH OF THE TOBACCO HORNWORM, MANDUCA SEXTA |